IRAK1 and neoplasm: We monitored the volume of xenograft tumors and found that the silencing of IRAK1 significantly slowed tumor growth in vivo (tumor volume in NC vs sh-IRAK1 group: 941.9 ± 104.4 vs 377.0 ± 52.5 mm3, Figures 10(i)and 10(j)).